Our goal is to provide relevant content about all medical diseases and conditions to assist healthcare providers, patient warriors, and patient advocates.
🚨April is #IBS Awareness Month!
#IrritableBowelSyndrome (IBS) affects millions worldwide, yet it often goes undiagnosed or misunderstood. This month, we invite our viewers to tune into an in-depth peer-to-peer conversation regarding IBS-C.
#IBSAwarenessMonth#PatientCare
In a conversation between @isatishrao; @dbrennerGIMD; Bryan Curtin, MD, MHSc; Kumkum Patel, MD, MPH; and Jodi Beth Khouri, PA-C, the panel discusses a new class of treatment for IBS-C: retainagogues.
Learn more about Retainagogues using the link below!
https://t.co/674b8rMyoN
👥 In a peer-to-peer roundtable discussion, @isatishrao; @dbrennerGIMD; Bryan Curtin, MD, MHSc; Kumkum Patel, MD, MPH; and Jodi Beth Khouri, PA-C, discuss the current state of care for patients with irritable bowel syndrome with constipation.
Watch here:
https://t.co/se7K9ajqP5
In this episode of The Spotlight Series Podcast, host Mario Nacinovich speaks with Lucinda Harris, MD, MS, of the Mayo Clinic, about #IrritableBowelSyndrome with #constipation (#IBS-C).
https://t.co/qyIzQglyNx
🩺 During a plenary session at the First Annual Conference in Bedside Medicine, hosted by @NorthwesternMed and Brian T. Garibaldi, MD and Andrew Elder, MBChB opened his ‘literal’ doctor’s bag to highlight the tools behind strong bedside skills.
🔗 ⤵️
https://t.co/rAK8X4fQzx
@NorthwesternMed hosted the First Annual Conference in #BedsideMedicine on November 14-15 in Chicago. The meeting brought together a collection of speakers from across the US and internationally who are the leading educators in bedside skills.
🔗: https://t.co/29e5w2xSP3
An observational electronic health record study suggests that initiation of tenapanor for irritable bowel syndrome with constipation (IBS-C) may significantly reduce healthcare utilization among high-need patients.
🔗: https://t.co/9uVsYlrMT7
#IrritableBowelSyndrome
🎥 In the 2nd video in a series focused on Bedside Medicine, Brian Garibaldi, MD speaks on his plans for the center and about an exciting upcoming bedside medicine event.
🔗: https://t.co/7euTmM5NrX
💻 Learn more about the bedside medicine conference::https://t.co/URtnk4sJV9
Exploring IBS‑C treatments 💡
In this clip, @dbrennerGIMD, of Northwestern University, explains why he makes treatment a collaborative effort with his patients. 🩺
Click the 🔗 below for more.
https://t.co/Cvktyd009Q
#MedJournal360#IBS#Gastroenterology#DigestiveHealth
📣 MJ360 has launched a new video series focused on #BedsideMedicine. In partnership w/ renowned expert Dr. Nayan Kothari, MJ360 is bringing you information and related to this successful approach to #PatientCare.
👂 Hear from Dr. Kothari
https://t.co/10flOdlrbm
#BedsideManners
🤔 What is the Phreedom Foundation?
👥 It's on a mission to empower lives, one family and one screen at a time. The founder, @nidhiguptatweet, spoke with MJ360 to discuss the genesis of the initiative.
📲Find out more⬇️
https://t.co/cuFUhDH4QX
#DigitialWellness#DigitalDetox
@dbrennerGIMD and KumKum Patel, MD continue their conversation on irritable bowel syndrome with constipation by highlighting the real-world impacts this condition has on patients’ daily life.
🔗: https://t.co/6PjnzRbhxI
#MedJournal360#IBS#IrritableBowelSyndrome#QualityOfLife
Patients with higher-risk myelodysplastic syndromes (HR-MDS) in the U.S. often experience long delays in diagnosis, face unmet social needs, and receive suboptimal treatment, according to a study.
Read more:
https://t.co/8rT5PaGqmx
#MedJournal360#Hematology#Hematologist
Children and adolescents with #SmithLemliOpitzSyndrome (SLOS) are more prone to dental and oral health problems, such as occlusal abnormalities, crowding, gingivitis, and more severe tooth decay, according to a study.
Read more:
https://t.co/8xhI94cbxP
#SLOS#OralHealth#Dental
Arthur Yee, MD, PhD, of NYU Grossman School of Medicine, explains why it's important to not just treat to tolerate #Gout, but to treat to prevent future flares.
Use the link below to start watching our full roundtable series.
https://t.co/fr5HJaq7Hx
#ChronicGout#ChronicPain
Michael Toprover, MD, of NYU Grossman School of Medicine, highlights his thoughts on patients with chronic gout who have been referred to a rheumatologist.
Use the link below to start watching.
https://t.co/fr5HJaq7Hx
#MedJournal360#ChronicGout#Gout#Arthritis#ChronicPain
NPH is a progressive neurological disease caused by an accumulation of cerebrospinal fluid (CSF). There is good news for patients: symptoms are largely reversible with treatment, especially if administered early.
Read more:
https://t.co/tgGlFS1h7u
#Neurology#Hydrocephalus
The US Food and Drug Administration (FDA) has accepted for priority review the New Drug Application (NDA) for TransCon CNP (navepegritide) for the treatment of children with achondroplasia.
Read more⤵️
https://t.co/Zv04cYmJHb
#FDA#Achondroplasia#Endocrinology#Endocrinologist
Many patients with chronic refractory gout (CRG) in the US fail to achieve target serum urate levels despite standard treatments, leading to frequent flares and high healthcare use, according to a study.
Read more ⤵️
https://t.co/7UQs5HJkr8
#Gout#ChronicGout#Rheumatology